Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ASCA101Phase 21 trial
MetaFines · Cachexia; Cancer
- ASKG915Phase 21 trial
AskGene Pharma, Inc. · Advanced Solid Tumors
- ASN-3186Phase 21 trial
Jiangsu Yahong Meditech Co., Ltd aka Asieris · Advanced Solid Tumors
- ASP2998Phase 21 trial
Astellas · Locally Advanced or Metastatic Malignant Solid Tumors
- ASP388BPhase 21 trial
Astellas · Locally Advanced or Metastatic Solid Tumors
- ASP5541PRL-02Phase 21 trial
Astellas · Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer, Metastatic Hormone Sensitive Prostate Cancer
- AST-201Phase 21 trial
Aston Sci. Inc. · Advanced Ovarian Cancer
- AST-301pNGVL3-hICDPhase 21 trial
Aston Sci. Inc. · Gastric Cancer
- ASTX660Phase 21 trial
Taiho Oncology, Inc. · Solid Tumors, Lymphoma
- atamparibPhase 21 trial
Nerviano Medical Sciences (Shanghai) Ltd. · NSCLC Adenocarcinoma, Solid Tumor
- atilizumabPhase 21 trial
Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma
- ATRN-119Phase 21 trial
Aprea Therapeutics · Advanced Solid Tumor
- ATTR-01Phase 21 trial
Accession Therapeutics Limited · Solid Tumor, Adult
- ATX-295Phase 21 trial
Accent Therapeutics · Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer
- ATX-898Phase 21 trial
Antares Therapeutics, Inc · Advanced Solid Tumors
- AU-007Phase 21 trial
Aulos Bioscience, Inc. · Advanced Solid Tumor, Metastatic Cancer, Cutaneous Melanoma
- AVZO-023Phase 21 trial
Avenzo Therapeutics, Inc. · HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
- AVZO-103Phase 21 trial
Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors
- AVZO-1418Phase 21 trial
Avenzo Therapeutics, Inc. · Solid Tumor Cancer, Locally Advanced, Metastatic Solid Tumors
- AZD0516Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD0754Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD2811Phase 21 trial
AstraZeneca · Small-Cell Lung Cancer
- AZD4360Phase 21 trial
AstraZeneca · Gastric Cancer, Gastroesophageal Junction Cancer, Biliary Tract Cancer
- AZD4635Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung
- AZD4956Phase 21 trial
AstraZeneca · Solid Tumours
- AZD5851Cell TherapyPhase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- AZD5863Phase 21 trial
AstraZeneca · Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma
- AZD6621Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD6750Phase 21 trial
AstraZeneca · Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin)
- AZD7789Phase 21 trial
AstraZeneca · Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer
- AZD8205Phase 21 trial
AstraZeneca · Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer
- AZD8359Phase 21 trial
AstraZeneca · Metastatic Prostate Cancer
- AZD8421Phase 21 trial
AstraZeneca · ER+ HER2- Advanced Breast Cancer, High-grade Serous Ovarian Cancer (HGSOC)
- AZD9750Phase 21 trial
AstraZeneca · Prostate Cancer
- AZD9793Phase 21 trial
AstraZeneca · Hepatocellular Carcinoma
- B group Purinostat MesylatePhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
- B013Phase 21 trial
Shanghai Jiaolian Drug Research and Development Co., Ltd · Platinum-resistant Recurrent Ovarian Cancer
- BalstililmabPhase 21 trial
Nelum Corp · Untreated, Advanced Pancreatic Cancer
- BAT1006Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAT8008Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAT8010Phase 21 trial
Bio-Thera Solutions · Advanced Solid Tumors
- BAY 3713372Phase 21 trial
Bayer · MTAP-deleted Solid Tumors
- BB-1701Phase 21 trial
Eisai · Breast Cancer
- BB102Phase 21 trial
Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)
- BBT-207Phase 21 trial
Bridge Biotherapeutics, Inc. · EGFR Mutant Advanced Non-Small Cell Lung Cancer
- BC3195Phase 21 trial
Biocity Biopharmaceutics Co., Ltd. · Locally Advanced or Metastatic Solid Tumors
- BCB-276Phase 21 trial
BrainChild Bio, Inc · Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor
- BCD-236Phase 21 trial
Biocad · Triple Negative Breast Cancer
- BDC-4182Phase 21 trial
Bolt Biotherapeutics, Inc. · Gastric Cancer Adenocarcinoma Metastatic, Gastroesophageal Adenocarcinoma
- BerubicinPhase 21 trial
CNS Pharmaceuticals, Inc. · Glioblastoma Multiforme, Adult
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.